Formulation and In-vitro Characterisation of nasal In-Situ Gel for treatment of Anti-migraine Drug

Authors

  • Ashwin Pahurkar Department of Pharmaceutics, Vidyabharti College of Pharmacy , Amravati, C.K. Naidu road,camp, Amravati ,SGBAU Maharashtra, India
  • Dr. Nishan N. Bobade Department of Pharmaceutics, Vidyabharti College of Pharmacy , Amravati, C.K. Naidu road,camp, Amravati ,SGBAU Maharashtra, India
  • Dr. Shrikant D. Pande Department of Pharmaceutics, Vidyabharti College of Pharmacy , Amravati, C.K. Naidu road,camp, Amravati ,SGBAU Maharashtra, India
  • Dr. Sandeep C. Atram Department of Pharmaceutics, Vidyabharti College of Pharmacy , Amravati, C.K. Naidu road,camp, Amravati ,SGBAU Maharashtra, India
  • Dr. Vikrant P. Wankhade Department of Pharmaceutics, Vidyabharti College of Pharmacy , Amravati, C.K. Naidu road,camp, Amravati ,SGBAU Maharashtra, India

DOI:

https://doi.org/10.22270/ajprd.v14i4.1849

Abstract

The present study aimed to develop and evaluate a temperature-dependent nasal in situ gel of Rizatriptan benzoate for enhanced nasal residence time and improved bioavailability in migraine therapy. Rizatriptan benzoate undergoes extensive first-pass metabolism, resulting in low oral bioavailability. To overcome this limitation, a thermosensitive nasal in situ gel system was prepared using polymers such as Chitosan HCl, Sodium β-Glycerophosphate, Sodium alginate, and Gellan gum. The formulations were evaluated for physicochemical parameters including pH, gelation temperature, viscosity, mucoadhesive strength, drug content, and in vitro drug release. The optimized formulation FF5 showed satisfactory gelation at nasal temperature, good mucoadhesion, and sustained drug release over 8 hours. Drug release kinetics revealed diffusion-controlled release following the Higuchi model. Stability studies indicated that the optimized formulation remained stable under different storage conditions. The developed temperature-dependent nasal in situ gel demonstrated potential as an effective and patient-friendly approach for sustained nasal delivery of Rizatriptan benzoate.

 

Downloads

Download data is not yet available.

References

Gholizadeh H, Cheng S, Pozzoli M, Messerotti E, Traini D, Young P, et al. Smart thermosensitive chitosan hydrogel for nasal delivery of ibuprofen to treat neurological disorders. Expert Opinion on Drug Delivery. 2019;16(4):453–466. doi:10.1080/17425247.2019.1597051.

Qian L, Zhang H, Wang J. In situ gels for nasal delivery: formulation, strategies and therapeutic applications. Advanced Drug Delivery Reviews. 2025. Available from: Pharma Excipients PDF

Prabhjot K, Tarun G, Goutam R, Amit G. In situ nasal gel drug delivery: a novel approach for brain targeting through the mucosal membrane. Artificial Cells, Nanomedicine and Biotechnology. 2016;44(4):1167–1176.

Durgapal S, Rana M, Mukhopadhyay S, Rana AJ, Goswami L, Joshi S. Formulation and evaluation of in-situ nasal gel of montelukast sodium for effective treatment of asthma. International Journal of Pharmaceutical Sciences and Research. 2018;9(7):2792–2799.

Nirmal HB, Bakliwal SR, Pawar SP. In-situ gel: new trends in controlled and sustained drug delivery system. International Journal of PharmTech Research. 2010;2(2):1398–1408.

Karunakaran R, Nair SS, Pimpalshende PM, Devi D, Kanika, Sachan K, et al. Formulation, optimization, and characterization of a thermosensitive in situ nasal gel incorporating chitosan nanoparticles of zolmitriptan for the management of acute migraine attacks. The Bioscan. 2025;20(Suppl 2):596–605. doi:10.63001/tbs.2025.v20.i02.S2.pp596-605.

Omar MM, Eleraky NE, El Sisi AM, Hasan OA. Development and evaluation of in-situ nasal gel formulations of nanosized transferosomal sumatriptan: design, optimization, in vitro and in vivo evaluation. Drug Design, Development and Therapy. 2019;13:4413–4430. doi:10.2147/DDDT.S235004.

Singh M, Kumar S, Vinayagam R, Samivel R. Thermosensitive mucoadhesive intranasal in situ gel for nose-to-brain targeting: physiochemical and pharmacokinetics study. Pharmaceuticals. 2025;18(6):871. doi:10.3390/ph18060871.

Thermoreversible biogels for intranasal delivery of rizatriptan benzoate. Available from: Academia PDF

Devasani SR, Asish D, Rathod S, Ganesh D. An overview of in situ gelling systems. Pharmaceutical and Biological Evaluations. 2016;3(1):60–69.

Bhanu P Sahua, Hemanta k Shannab, Mohan K Dm, Dewin, ad evaluation of a Mucoadhesive nasal of prepared mucoadhesive substance of Dioaua althea L. Asian Jounnit of Parmaceutical Sciences, no.5 (175-187.)

Basu,Shyamoshree, and Amol K. Bandyopadhyay "Comparative Study between Conventional and Thermoreversible mucoadhesive Nasal Gels of Midazolam Hydrochloride Science and Technology 2, no.2 (2012) 8-15.

Mehta, M. R, S. A. Surve, and M. D. Menon. "Novel nasal in situ gelling systems bent of sinusitis." Indian journal of pharmaceutical sciences 71, no. 6 (2009):721.

Vinay Wamorkar, M. Mohan Varma and Manjunaih SY, International Journal of research in Pharmaceutical and Biomedical Sciences, (2), ppm53, 2006.

Belgawar, Veena S., Dheeraj S. Chauk, Hitendra S. Mahajan, Snehal A. Jain, Send G. Gattani, and Sanjay 3 Surana. "Formulation and evaluation of in situ pelling an of dimenhydrinate for nasal administration." Pharmaceutical development and addogy 14, no.3 (2009) 240-248.

Reddy, K. Ravindra, M. Ravi Shankar Yadav, and P. Sabitha Reddy. "Preparation and tion of Aceclofenac ophthalmic in-situ gels. "Journal of Chemical Biological and Physical Somes (CBPS) 1, no.2 (2011) 289.

Ellady, SS Abd, NabedD. Mortada, Gehanne AS Awad, Noha M. Zaki, and Ragis A. Taha Development of in situ gelling and mucoadhesive mebeverine hydrochloride Solution for rectaal altinistration." Saudi pharmaceutical journal 11 no.4 (2003) 59-171.

Maitani, Yoshie. Setuko Asano, Satomi Takahashi, Masayuki Nakagaki, and tsunami nagai Permeability of insulin entrapped in liposome through the nasal mucosa of rabbits" chemical and pharmaceutical bulletin 40, no.6 (1992) 1569-1572

Wadell, Cecilia, Erik Bjork, and Ola Camber. "Nasal drug delivery evaluation of an in Vitro model using porcine nasal mucosa." European Journal of pharmaceutical sciences 7, no 3 (1999) 197-206.

TAS, Cetin, Cansel koseOzkan, Ayhan Savaser, YalcinOzkan, Umut Tas Hikmet Altunay. "Nasal absorption of metoclopramide from different Carbopol® 981 based Ilions In vitro, ex vivo and in vivo evaluation." European journal of pharmaceutics and biopharmaceutics 64, no.2 (2006) 246-254.

59. Ugwoke, Michael Ikechukwu, ExaudSam, Guy Van Den Mooter, Norbert verbeke and Renaar kinget. "Nasal mucoadhesive delivery systems of the anti-parkinsonian drug apomorphine influence of drug-loading on in vitro and in vivo release in rabbits. "International of pharmaceutics 181, no. 1(1999) 125-138

Higuchi T. Mechanism of sustained-action medication: theoretical analysis of rate of release of solid drugs dispersed in solid matrices. Journal of Pharmaceutical Sciences, 52(12), pp 1145-1149.

Korsmeyer RW, Gurny R, Doelker E, Buri P, Peppas NA. Mechanisms of solute release from porous hydrophilic polymers. International Journal of Pharmaceutics, 15(1), pp 25-35.

Peppas NA. Analysis of Fickian and non-Fickian drug release from polymers. Pharmaceutica Acta Helvetiae, 60(4), pp 110-111.

Sopyan I, Gozali D, Sriwidodo, Guntina RK. Design-Expert Software (DOE): An Application Tool for Optimization in Pharmaceutical Preparations Formulation. International Journal of Applied Pharmaceutics, 14(4), pp 1-9 (2022).

Emam MF, El-Ashmawy AA, Mursi NM, Emara LH. Optimization of Meloxicam Solid Dispersion Formulations for Dissolution Enhancement and Storage Stability Using 3³ Full Factorial Design Based on Response Surface Methodology. AAPS PharmSciTech, 23(8), pp 1-14 (2022).

UgwokeMI Agu Ro, JorisseM. Augustijn P. Sciot R. Verbeke N, et al. Toxicological investigations of the effects of carboxymethyl cellulose on ciliary beat frequency of human epithelial cells in primary suspension culture and in vivo on rabbit nasal mucosa. Int. J. Pharm 2000 201 33-51.

Guideline. ICH Harmonised Tripartite Stability testing of new drug substances and Products QIA (R2), Current Step 4.2003.

Published

2026-08-15

How to Cite

Ashwin Pahurkar, Dr. Nishan N. Bobade, Dr. Shrikant D. Pande, Dr. Sandeep C. Atram, & Dr. Vikrant P. Wankhade. (2026). Formulation and In-vitro Characterisation of nasal In-Situ Gel for treatment of Anti-migraine Drug. Asian Journal of Pharmaceutical Research and Development, 14(4), 36–45. https://doi.org/10.22270/ajprd.v14i4.1849